NEA Management Company, LLC - Q2 2021 holdings

$7.68 Billion is the total value of NEA Management Company, LLC's 63 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 33.3% .

 Value Shares↓ Weighting
COUR SellCOURSERA INC$656,817,000
-31.0%
16,603,063
-21.5%
8.56%
-60.0%
DM SellDESKTOP METAL INC$223,222,000
-47.3%
19,410,631
-31.7%
2.91%
-69.4%
EAR SellEARGO INC$180,420,000
-44.6%
4,520,670
-30.7%
2.35%
-67.9%
OPEN SellOPENDOOR TECHNOLOGIES INC$59,090,000
-58.2%
3,333,276
-50.0%
0.77%
-75.7%
AFMD SellAFFIMED NV$37,625,000
-12.0%
4,426,488
-18.1%
0.49%
-49.0%
UPST SellUPSTART HLDGS INC$35,858,000
-51.5%
287,092
-49.9%
0.47%
-71.8%
DZSI ExitDZS INC$0-38,470
-100.0%
-0.01%
MLND ExitMILLENDO THERAPEUTICS INC$0-1,766,779
-100.0%
-0.05%
SPT ExitSPROUT SOCIAL INC$0-1,545,040
-100.0%
-2.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-02
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GLYCOMIMETICS INC39Q3 20237.6%
AURINIA PHARMACEUTICALS INC37Q3 20235.0%
CHAMPIONS ONCOLOGY INC33Q3 20231.2%
LEXICON PHARMACEUTICALS INC32Q3 20232.0%
ADAPTIMMUNE THERAPEUTICS PLC31Q3 20239.3%
TREVENA INC31Q3 20213.3%
AKARI THERAPEUTICS PLC31Q2 20230.3%
ARDELYX INC29Q3 202111.9%
RIGEL PHARMACEUTICALS INC29Q2 20200.6%
EPIZYME INC28Q1 20209.6%

View NEA Management Company, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-10
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-12

View NEA Management Company, LLC's complete filings history.

Compare quarters

Export NEA Management Company, LLC's holdings